According to XYZResearch study, over the next five years the Adalimumab Biosimilarmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Adalimumab Biosimilarbusiness.
Adalimumab Biosimilar market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Adalimumab Biosimilar for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Adalimumab Biosimilar market competition by top manufacturers/players, with Adalimumab Biosimilar sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Tablet
Oral Solution
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Adalimumab Biosimilar for each application, including
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Feel free to let me know if you have any special requirements.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Adalimumab Biosimilar Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Tablet
2.1.2 Oral Solution
2.2 Overall Market Performance(Value)
2.2.1 Tablet
2.2.2 Oral Solution
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
4 Manufacturers Profiles/Analysis
4.1 AET BioTech
4.1.1 AET BioTech Profiles
4.1.2 AET BioTech Product Information
4.1.3 AET BioTech Adalimumab Biosimilar Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 AET BioTech SWOT Analysis
4.2 Amgen
4.2.1 Amgen Profiles
4.2.2 Amgen Product Information
4.2.3 Amgen Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Amgen SWOT Analysis
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Profiles
4.3.2 Boehringer Ingelheim Product Information
4.3.3 Boehringer Ingelheim Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Boehringer Ingelheim SWOT Analysis
4.4 Coherus Biosciences
4.4.1 Coherus Biosciences Profiles
4.4.2 Coherus Biosciences Product Information
4.4.3 Coherus Biosciences Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Coherus Biosciences SWOT Analysis
4.5 Fujifilm Kyowa Kirin Biologics
4.5.1 Fujifilm Kyowa Kirin Biologics Profiles
4.5.2 Fujifilm Kyowa Kirin Biologics Product Information
4.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Fujifilm Kyowa Kirin Biologics SWOT Analysis
4.6 LG Life Sciences/Mochida Pharmaceutical
4.6.1 LG Life Sciences/Mochida Pharmaceutical Profiles
4.6.2 LG Life Sciences/Mochida Pharmaceutical Product Information
4.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 LG Life Sciences/Mochida Pharmaceutical SWOT Analysis
4.7 Momenta Pharmaceuticals
4.7.1 Momenta Pharmaceuticals Profiles
4.7.2 Momenta Pharmaceuticals Product Information
4.7.3 Momenta Pharmaceuticals Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Momenta Pharmaceuticals SWOT Analysis
4.8 Oncobiologics
4.8.1 Oncobiologics Profiles
4.8.2 Oncobiologics Product Information
4.8.3 Oncobiologics Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Oncobiologics SWOT Analysis
4.9 Pfizer
4.9.1 Pfizer Profiles
4.9.2 Pfizer Product Information
4.9.3 Pfizer Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Pfizer SWOT Analysis
4.10 Samsung Bioepsis
4.10.1 Samsung Bioepsis Profiles
4.10.2 Samsung Bioepsis Product Information
4.10.3 Samsung Bioepsis Adalimumab BiosimilarSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Samsung Bioepsis SWOT Analysis
4.11 Sandoz
4.12 Zydus Cadila
5 Market Performance for Manufacturers
5.1 Global Adalimumab Biosimilar Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Adalimumab Biosimilar Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Adalimumab Biosimilar Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Adalimumab Biosimilar Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Adalimumab Biosimilar Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Adalimumab Biosimilar Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Adalimumab Biosimilar Market Assessment by Regions (2014-2020)
7.1 Global Adalimumab Biosimilar Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Adalimumab Biosimilar Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Adalimumab Biosimilar Price (USD/Unit) by Regions 2014-2020
7.4 Global Adalimumab Biosimilar Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Adalimumab Biosimilar Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Hospital Pharmacy Industry
11.2 Retail Pharmacy Industry
11.3 Online Pharmacy Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Adalimumab Biosimilar Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Adalimumab Biosimilar Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Tablet
12.2.3 Oral Solution
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Hospital Pharmacy
12.3.3 Retail Pharmacy
12.3.4 Online Pharmacy
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Adalimumab Biosimilar Price (USD/Unit) Trend 2021-2026
12.4.2 Global Adalimumab Biosimilar Gross Profit Trend 2021-2026
13 Conclusion
The Automatic Sales Enablement System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Executive Summary
Azoth Analytics has released a research report titled "Global Bluetooth Devices Market (2024 Edition)" which provides a complete analysis of the Global Bluetooth Devices Market industry in terms of Value (USD Billion) and Volume (Million Units), market segmentation by ...
Executive Summary
Azoth Analytics has released a research report titled "Global Wide Light Truck Tyres (WLTR) Market (2024 Edition)" which provides a complete analysis of the Global Wide Light Trucks Tyres (WLTR) industry in terms of market segmentation By Type (Radial and Bias), By Tru...
Asia Pacific drone payload market will grow by 14.2% annually with a total addressable market cap of $67.15 billion over 2024-2033. The growth is driven by increasing applications of drones, rising defense investments in unmanned technologies, the development of advanced drone payload systems, incre...
Europe drone payload market was valued at $1,93 billion in 2023 and will grow by 12.3% annually over 2023-2033. The growth is driven by increasing applications of drones, rising defense investments in unmanned technologies, the development of advanced drone payload systems, increase in market for lo...
North America drone payload market is projected to grow by 11.7% annually in the forecast period and reach $11.71 billion by 2033. The growth is driven by increasing applications of drones, rising defense investments in unmanned technologies, the development of advanced drone payload systems, increa...
Global drone payload market will reach 33.86 billion by 2033, growing by 12.8% annually over 2023-2033. The growth is driven by increasing applications of drones, rising defense investments in unmanned technologies, the development of advanced drone payload systems, increase in market for location-b...
The Home After-Sales Service Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Overview of the Global Sales Success Training Market:
The report discusses everything a marketer requires before investing in the global Sales Success Training Market during the forecast period 2023-2030. It provide...
Overview of the Global Ticket Sales and Booking Software Market:
The report discusses everything a marketer requires before investing in the global Ticket Sales and Booking Software Market during the forecast period...